In addition, consistent with the expression of CAPS and WFDC2 in nasopharyngeal carcinoma, Kaplan Meier’s survival analysis exhibited the remarkable prolongation of the overall survival periods in the patients with low CAPS and WFDC2 (Fig. 7). The gene discussed is CAPS; the disease is nasopharyngeal carcinoma.